Tuesday, April 04, 2023 11:03:01 AM
Recent CDLX News
- Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- Liane Hornsey Appointed to Cardlytics Board of Directors • GlobeNewswire Inc. • 04/09/2024 08:02:00 PM
- Cardlytics Prices $150.0 Million Convertible Senior Notes Offering • GlobeNewswire Inc. • 03/27/2024 01:15:16 AM
- Cardlytics Announces Proposed Convertible Senior Notes Offering • GlobeNewswire Inc. • 03/26/2024 11:13:12 AM
- Adobe Stock Drops Following Below-Estimate Projections, Cardlytics Surges with Unexpected Profit, and More News • IH Market News • 03/15/2024 11:30:55 AM
- Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/14/2024 08:03:00 PM
- Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/08/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:24:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 12:40:13 AM
- Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast • GlobeNewswire Inc. • 02/29/2024 09:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/12/2024 05:15:21 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 09:09:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 12:58:27 PM
- Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results • GlobeNewswire Inc. • 01/29/2024 12:56:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/29/2024 12:35:31 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/29/2024 12:34:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 11:21:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 09:08:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 09:30:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:20:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 01:00:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:59:50 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2024 09:50:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2024 09:49:22 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM